Fannie Mae, Freddie Mac shares tumble after conservatorship comments
LONDON - Eden Research plc (AIM:EDEN), a company specializing in sustainable biopesticide and biocontrol technologies, has announced an upcoming live presentation for investors. The event, scheduled for February 13, 2025, at 11:00 GMT, will feature CEO Sean Smith and CFO Alex Abrey. It aims to engage both current and prospective shareholders and will be hosted via the Investor Meet Company platform.
The presentation will address the company’s advancements and strategies in developing biopesticide products and natural microencapsulation technologies for agriculture, animal health, and consumer products. Eden Research is noted for its focus on terpene-based products, which are derived from natural plant defense metabolites and have been used primarily on high-value fruits and vegetables.
Eden’s portfolio includes Mevalone®, a foliar biofungicide, NovellusÒ+, an evolved version of Mevalone with broader applications, and Cedroz™, a bionematicide targeting parasitic worms. Additionally, the company has developed Ecovelex™, a seed treatment product designed to repel birds without harming them, using Eden’s plant-derived chemistry and Sustaine® microencapsulation system.
The Sustaine® technology is notable for being a plastic-free, biodegradable alternative to traditional microplastics in encapsulation, aligning with global efforts to reduce microplastics pollution.
Eden Research, listed on the AIM market of the London Stock Exchange (LON:LSEG) since May 11, 2012, has also been recognized with the London Stock Exchange Green Economy Mark since January 2021. This distinction is given to companies generating over 50% of their annual revenue from green economy products and services, with Eden attributing 100% of its revenue to sustainable offerings.
Interested investors can sign up and submit questions for the event through the Investor Meet Company platform until February 12, 2025, at 09:00 GMT. Those already following Eden on the platform will automatically receive an invitation to the presentation.
This article is based on a press release statement from Eden Research plc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.